Acute coronary syndrome.
Conditions
Interventions
Intervention 1: Intervention group: The intervention group received one 500 mg Curcuma Longa tablet once a day, 9 am after breakfast, for three days, in addition to routine regimen. Intervention 2: Co
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Diagnosis acute coronary syndrome Patient consent for participation in the study Patient 45 to 75 years old Lack of active mental illness, mental retardation, deafness, blindness Lack of sensitivity to Curcuma Longa Lack of addiction to alcohol and Opioid Patients who are able to speak and understand language and conscious No history of sleeping drugs consumption Chest pain score greater than four Systolic blood pressure 90-100 mmHg
Exclusion criteria
Exclusion criteria: Pregnant women Patients with gallstones or bile disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chest pain. Timepoint: Evaluation of pain is performed before and half an hour after the intervention for three consecutive days. Method of measurement: Numeric Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Evaluation of sleep quality is performed before the intervention and three consecutive days. Method of measurement: St Mary's Hospital Sleep Questionnaires.;Hemodynamic indicators. Timepoint: Evaluation of hemodynamic parameters is performed before and half an hour after the intervention for three consecutive days. Method of measurement: Monitor of Pooyandegan Rah-e-Salamat. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMonir Nobahar
Semnan University of Medical Sciences
Outcome results
None listed